Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

OOMEROS CORP

EconomyAI buildoutMarket MapFundsWatchlist
Log in
O

OMEROS CORP

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Omeros Corporation Reports Second Quarter 2026 Financial Results
    Aug 12, 2026Omeros Corp. Press Releases
  • Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026
    Aug 10, 2026Omeros Corp. Press Releases
  • CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA®
    Aug 3, 2026Omeros Corp. Press Releases
  • Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA
    Jun 26, 2026Omeros Corp. Press Releases
  • Omeros Announces Webcast Details for Annual Meeting of Shareholders
    Jun 15, 2026Omeros Corp. Press Releases
  • Omeros Corporation Reports First Quarter 2026 Financial Results
    May 13, 2026Omeros Corp. Press Releases
  • Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026
    May 11, 2026Omeros Corp. Press Releases
  • CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug)
    Apr 16, 2026Omeros Corp. Press Releases
  • Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results
    Mar 31, 2026Omeros Corp. Press Releases
  • Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026
    Mar 26, 2026Omeros Corp. Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
$21.05Close · Sep 22, 2026